Kai Li

机构：Changjiang Institute of Survey, Planning, Design and Research, Hubei Provincial Water Resources and Hydropower Planning Survey and Design Institute, Hunan Agricultural University · ORCID：0000-0002-1746-7913

发表论文 284 篇 · 总被引 6340 次 · h-index 38

代表论文

• PGLYRP2 drives hepatocyte-intrinsic innate immunity by trapping and clearing hepatitis B virus (2025 · Journal of Clinical Investigation · 被引 35)
• Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition) (2024 · BioScience Trends · 被引 20)
• Dynamic prognostication and treatment planning for hepatocellular carcinoma: A machine learning-enhanced survival study using multi-centric data (2025 · The Innovation Medicine · 被引 15)
• Nucleic acid-based reference materials: A “ruler” for precision molecular diagnostics (2025 · TrAC Trends in Analytical Chemistry · 被引 8)
• Methods for detecting off-target effects of CRISPR/Cas9 (2025 · Biotechnology Advances · 被引 6)
• Identification and Pathogenicity Analysis of Feline Calicivirus in Shanghai and Guangdong, China (2025 · Transboundary and Emerging Diseases · 被引 4)